TY - JOUR
T1 - From hype to hope
T2 - Considerations in conducting robust microbiome science
AU - McGuinness, Amelia J.
AU - Stinson, Lisa F.
AU - Snelson, Matthew
AU - Loughman, Amy
AU - Stringer, Andrea
AU - Hannan, Anthony J.
AU - Cowan, Caitlin S.M.
AU - Jama, Hamdi A.
AU - Caparros-Martin, Jose A.
AU - West, Madeline L.
AU - Wardill, Hannah R.
N1 - Funding Information:
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. AJ McGuinness is funded through the NHMRC supported Centre for Research Excellence for the Development of Innovative Therapies (CREDIT CRE). CSM Cowan is supported by a National Health and Medical Research Council Investigator Grant (APP1196783). HR Wardill is supported by the Hospital Research Foundation Group. M Snelson is supported by a National Heart Foundation Postdoctoral Fellowship (106698). LF Stinson is supported by the Stan Perron Charitable Foundation and an unrestricted grant provided by Medela AG, administered through The University of Western Australia. AJ Hannan in supported by a NHMRC Ideas Grant and EU-JPND Grant.
Funding Information:
The importance of methodology standards for quality and consistency has been widely acknowledged. The International Human Microbiome Standards project ( http://www.microbiome-standards.org/ , 2011–2015) was funded by the European Commission to develop standards and guidelines for microbiome-related methodologies, and has published protocols for the collection, processing, sequencing, and analysis of human microbiome samples. Some similar undertakings include the UK National Institute for Biological Standards and Control reagent reference standards ( Amos et al., 2020 ) and the Quadram Institute’s “Best Practice in Microbiome Research” protocols ( https://quadram.ac.uk/best-practice-in-microbiome-research/ ), as well as independent efforts ( Bharti and Grimm, 2021 ). Unfortunately, it is unclear whether any group has taken the mantle internationally to provide updates that are comprehensive and keep pace with the rapid development and innovation in methods.
Funding Information:
The increasing support for open science, and widespread availability of data hosting and sharing platforms and standards, will also help with reproducibility, particularly if raw data are made available so that pipelines can be replicated. Data availability is also critical for meta-analyses since microbial pipelines need to be harmonised to quantitatively compare and synthesise findings across studies. The former coordinator of the Human Microbiome Project called for formal management of microbiome data sharing, which requires investment in scientific infrastructure to enable all the determinants of reproducibility, not just for the research itself. There are numerous microbiome centres around the world, and cooperation in a common goal, such as reproducibility, would be a rising tide that floats all boats. Whilst national (e.g., Canadian Microbiome Initiative; HMP; Alliance Promotion Microbiote) and international (IHMC, and MicrobiomeSupport, funded by European Union’s Horizon 2020 research and innovation programme) efforts exist, a global coalition of them would be greater than the sum of its parts.
Publisher Copyright:
© 2023 The Author(s)
PY - 2024/1
Y1 - 2024/1
N2 - Microbiome science has been one of the most exciting and rapidly evolving research fields in the past two decades. Breakthroughs in technologies including DNA sequencing have meant that the trillions of microbes (particularly bacteria) inhabiting human biological niches (particularly the gut) can be profiled and analysed in exquisite detail. This microbiome profiling has profound impacts across many fields of research, especially biomedical science, with implications for how we understand and ultimately treat a wide range of human disorders. However, like many great scientific frontiers in human history, the pioneering nature of microbiome research comes with a multitude of challenges and potential pitfalls. These include the reproducibility and robustness of microbiome science, especially in its applications to human health outcomes. In this article, we address the enormous promise of microbiome science and its many challenges, proposing constructive solutions to enhance the reproducibility and robustness of research in this nascent field. The optimisation of microbiome science spans research design, implementation and analysis, and we discuss specific aspects such as the importance of ecological principals and functionality, challenges with microbiome-modulating therapies and the consideration of confounding, alternative options for microbiome sequencing, and the potential of machine learning and computational science to advance the field. The power of microbiome science promises to revolutionise our understanding of many diseases and provide new approaches to prevention, early diagnosis, and treatment.
AB - Microbiome science has been one of the most exciting and rapidly evolving research fields in the past two decades. Breakthroughs in technologies including DNA sequencing have meant that the trillions of microbes (particularly bacteria) inhabiting human biological niches (particularly the gut) can be profiled and analysed in exquisite detail. This microbiome profiling has profound impacts across many fields of research, especially biomedical science, with implications for how we understand and ultimately treat a wide range of human disorders. However, like many great scientific frontiers in human history, the pioneering nature of microbiome research comes with a multitude of challenges and potential pitfalls. These include the reproducibility and robustness of microbiome science, especially in its applications to human health outcomes. In this article, we address the enormous promise of microbiome science and its many challenges, proposing constructive solutions to enhance the reproducibility and robustness of research in this nascent field. The optimisation of microbiome science spans research design, implementation and analysis, and we discuss specific aspects such as the importance of ecological principals and functionality, challenges with microbiome-modulating therapies and the consideration of confounding, alternative options for microbiome sequencing, and the potential of machine learning and computational science to advance the field. The power of microbiome science promises to revolutionise our understanding of many diseases and provide new approaches to prevention, early diagnosis, and treatment.
KW - Causality
KW - Machine learning
KW - Metabolomics
KW - Methodology
KW - Microbiome
KW - Microbiota
KW - Multi-omics
KW - Systems biology
UR - http://www.scopus.com/inward/record.url?scp=85174016248&partnerID=8YFLogxK
U2 - 10.1016/j.bbi.2023.09.022
DO - 10.1016/j.bbi.2023.09.022
M3 - Article
C2 - 37806533
AN - SCOPUS:85174016248
SN - 0889-1591
VL - 115
SP - 120
EP - 130
JO - Brain, Behavior, and Immunity
JF - Brain, Behavior, and Immunity
ER -